363 related articles for article (PubMed ID: 17003678)
1. Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women.
Blandford JM; Gift TL
Sex Transm Dis; 2006 Oct; 33(10 Suppl):S117-21. PubMed ID: 17003678
[TBL] [Abstract][Full Text] [Related]
2. Risk of sequelae after Chlamydia trachomatis genital infection in women.
Haggerty CL; Gottlieb SL; Taylor BD; Low N; Xu F; Ness RB
J Infect Dis; 2010 Jun; 201 Suppl 2():S134-55. PubMed ID: 20470050
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
Land JA; Van Bergen JE; Morré SA; Postma MJ
Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
[TBL] [Abstract][Full Text] [Related]
4. Estimation of the burden of disease and costs of genital Chlamydia trachomatis infection in Canada.
Tuite AR; Jayaraman GC; Allen VG; Fisman DN
Sex Transm Dis; 2012 Apr; 39(4):260-7. PubMed ID: 22421691
[TBL] [Abstract][Full Text] [Related]
5. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
[TBL] [Abstract][Full Text] [Related]
6. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
[TBL] [Abstract][Full Text] [Related]
7. [Smoking-attributable productivity loss in Germany--a partial sickness cost study based on the human capital potential method].
Wegner C; Gutsch A; Hessel F; Wasem J
Gesundheitswesen; 2004 Jul; 66(7):423-32. PubMed ID: 15314734
[TBL] [Abstract][Full Text] [Related]
8. [Chlamydia trachomatis, pelvic inflammatory diseases and sterility].
Pungetti D; Lenzi M; Muzzi Rossi P; Cantiero D; Zanardi E
Minerva Ginecol; 1993 Mar; 45(3):95-100. PubMed ID: 8332283
[TBL] [Abstract][Full Text] [Related]
9. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women.
Ness RB; Hillier SL; Kip KE; Richter HE; Soper DE; Stamm CA; McGregor JA; Bass DC; Rice P; Sweet RL
Am J Epidemiol; 2005 Jan; 161(2):186-95. PubMed ID: 15632269
[TBL] [Abstract][Full Text] [Related]
10. Use age to target chlamydial screening.
Contracept Technol Update; 1998 Aug; 19(8):104-5. PubMed ID: 12348576
[TBL] [Abstract][Full Text] [Related]
11. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia sequelae cost estimates used in current economic evaluations: does one-size-fit-all?
Ong KJ; Soldan K; Jit M; Dunbar JK; Woodhall SC
Sex Transm Infect; 2017 Feb; 93(1):18-24. PubMed ID: 27288417
[TBL] [Abstract][Full Text] [Related]
13. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003.
Ekwueme DU; Chesson HW; Zhang KB; Balamurugan A
Cancer; 2008 Nov; 113(10 Suppl):2936-45. PubMed ID: 18980277
[TBL] [Abstract][Full Text] [Related]
14. Chlamydia trachomatis genital infections--United States, 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(9):193-8. PubMed ID: 9072679
[TBL] [Abstract][Full Text] [Related]
15. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
16. Should asymptomatic patients be tested for Chlamydia trachomatis in general practice?
Buhaug H; Skjeldestad FE; Halvorsen LE; Dalen A
Br J Gen Pract; 1990 Apr; 40(333):142-5. PubMed ID: 2115349
[TBL] [Abstract][Full Text] [Related]
17. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
van Valkengoed IG; Postma MJ; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
Sex Transm Infect; 2001 Aug; 77(4):276-82. PubMed ID: 11463928
[TBL] [Abstract][Full Text] [Related]
19. Infertility as a sequela of chlamydial pelvic inflammatory disease.
Paavonen J; Vesterinen E; Mårdh PA
Scand J Infect Dis Suppl; 1982; 32():73-6. PubMed ID: 6958024
[TBL] [Abstract][Full Text] [Related]
20. Pelvic inflammatory disease following induced first-trimester abortion. Risk groups, prophylaxis and sequelae.
Heisterberg L
Dan Med Bull; 1988 Feb; 35(1):64-75. PubMed ID: 3277798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
